⌘K
Loading ticker…
As of 2026-08-24, West Pharmaceutical Services, Inc. (WST) has a 3-month relative strength percentile of 70 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 59. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 2.1%, relative volume 0.77×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
WST is in a stage 2 uptrend, week 4. Currently in a 36-day base; basing ADR 2.5% (broad 2.6%). VCP detected: inconclusive. RS line below base-start high. Distance from 50d / 200d: 1.5% / 21.6%.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
WST is held by 69 ETFs as of May 2026. Top owner: NOBL at 1.72% weight, $191M notional. Top 3 carry $310M.
Held by 222 ETFs · $4.0B across latest filings · largest weight 4.74% (TMFM).
Top 10 by value, from SEC N-PORT-P filings dated May 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| NOBLProShares S&P 500 Dividend Aristocrats ETF | 1.72% | $191M | +0.34 pp |
| VHTVanguard Health Care ETF | 0.37% | $70M | +0.10 pp |
| SCHGSchwab U.S. Large-Cap Growth ETF | 0.08% | $49M | +0.01 pp |
| SCHXSchwab U.S. Large-Cap ETF | 0.03% | $24M | — |
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| 0.07% |
| $15M |
| +0.01 pp |
| SCHBSchwab U.S. Broad Market ETF | 0.03% | $14M | — |
| FNDXSchwab Fundamental U.S. Large Company Index ETF | 0.03% | $8M | — |
| AVUSAvantis U.S. Equity ETF | 0.04% | $6M | — |
| OMFL | 0.12% | $6M | +0.08 pp |
| TMFM | 4.74% | $6M | +1.17 pp |
Showing 10 of 69 ETF owners.
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | WST Jan avg: 1.77% median: 5.10% win: 75% σ: 12.41% n: 4 2022-04-12 → 2026-07-31 | WST Feb avg: -1.62% median: 3.06% win: 50% σ: 22.38% n: 4 2022-04-12 → 2026-07-31 | WST Mar avg: 3.65% median: 3.92% win: 50% σ: 7.23% n: 4 2022-04-12 → 2026-07-31 | WST Apr avg: -2.65% median: -5.62% win: 40% σ: 14.98% n: 5 2022-04-12 → 2026-07-31 | WST May avg: -1.58% median: -1.49% win: 20% σ: 6.50% n: 5 2022-04-12 → 2026-07-31 | WST Jun avg: 5.22% median: 3.77% win: 60% σ: 7.33% n: 5 2022-04-12 → 2026-07-31 | WST Jul avg: 1.43% median: -3.77% win: 40% σ: 9.38% n: 5 2022-04-12 → 2026-07-31 | WST Aug avg: 0.64% median: 2.83% win: 75% σ: 10.20% n: 4 2022-04-12 → 2026-07-31 (current) | WST Sep avg: -5.73% median: -6.04% win: 25% σ: 9.62% n: 4 2022-04-12 → 2026-07-31 | WST Oct avg: -2.89% median: -1.95% win: 50% σ: 10.04% n: 4 2022-04-12 → 2026-07-31 | WST Nov avg: 4.06% median: 3.87% win: 75% σ: 5.11% n: 4 2022-04-12 → 2026-07-31 | WST Dec avg: 0.12% median: 0.34% win: 75% σ: 0.60% n: 4 2022-04-12 → 2026-07-31 |